takeda pharmaceutical co ltd
(4502:Tokyo Stock Exchange)
Transactions by TAKEDA PHARMACEUTICAL CO LTD (4502) in the last 6 months
BioMotiv, LLC announced that it has entered into a strategic partnership with new investor Takeda Pharmaceutical Company Limited for gross proceeds of $25,000,000 on September 25, 2014.
Medical Tribune Inc. acquired Nippon-Rinshosha Limited from Takeda Pharmaceutical Company Limited (TSE:4502) on September 2, 2014. As per the terms of the contract, Nippon-Rinshosha Limited will continue its current medical book publishing business activities as a company within the Medical Tribune group.
|Abbott Laboratories||$43.67 USD||-0.48|
|Astellas Pharma Inc||¥1,810 JPY||+43.00|
|Baxter International Inc||$70.73 USD||-0.15|
|Becton Dickinson and Co||$142.51 USD||-0.98|
|Shire PLC||4,836 GBp||-32.00|
|View Industry Companies|